Sentences with phrase «advanced cell therapy»

Format: Website Years Covered: Jan. 2011 - Dec. 2017 Search Strategy: Manually search a dozen registries by keywords Project Focus: any trials of advanced cell therapy, worldwide

Package of ALL advanced cell therapy trials registered internationally during 2017 contains 18 parameters for 638 trials and comes with free updates if we find more trials in this time frame.

NEW: This data set provides the sponsor and collaborators, lead investigator (s), and participating hospitals for all advanced cell therapy trials registered worldwide in 2017.

Monthly updates of 18 parameters for all new trials in advanced cell therapy.

When I started this project with PGCBF, we decided to use definition of Advanced Cell Therapy to set inclusion and exclusion criteria for the most comprehensive data capture.

Format: Website Years Covered: Cumulative to 31 October 2017 Search Strategy: Manually search a dozen registries by keywords Project Focus: On - line search portal of all currently recruiting cord blood trials, both advanced cell therapy and standard hematology / oncology, worldwide

Format: Website Years Covered: currently active UK trials as of June 2017 Search Strategy: Not disclosed Project Focus: advanced cell therapy, active that year, in the UK only Special Notes: on - line sort by 4 parameters, archives for previous years back to 2012.

NEW: Package of MSC advanced cell therapy trials registered internationally during 2017 contains 16 parameters for 145 trials.

We define Advanced Cell Therapy as all therapies in which cells are more than minimally manipulated, and / or their action is not homologous.

This project is presented in the Pioneer Advanced Cell therapy of the Epidermis (PACE) booklet.

In the last decade advanced cell therapies are becoming highly commercialized.

Not exact matches

«As a part of the Nohla team, I look forward to advancing the development of its cell therapy programs for patients with significant unmet needs.»

His research has spanned hematopoiesis, gene therapy, stem cell biology, genomics and cancer, consistently focusing on bringing the very latest research advances to patients with heretofore incurable diseases.

Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.

We are identifying and supporting work on the technologies of the future: in advanced manufacturing; renewable energy; cell therapy; interconnected digital; intelligent transport; and next generation computing.

A group of the nation's leading cancer research scientists and their Cuban counterparts are exploring how to advance cancer therapy, diagnosis, and prevention, including the use of immunotherapy to harness the body's immune systems to attack and eliminate cancer cells.

Based on results of the current study described in a report online June 18 in the journal Cancer Cell, Johns Hopkins researchers say they are planning a phase I clinical trial to test the paclitaxel - fostamatinib combination therapy in patients with recurrent advanced ovarian cancer.

Advanced Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocCell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastoccell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocyst.

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell therCell Therapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell tTherapy is an annual prize geared toward researchers focused on basic or translational research that advances regenerative medicine and cell thercell therapytherapy.

New products and developments, such as new drugs for cancer, fresh therapies for rare diseases, progress in medications for HIV / AIDS, and advances in stem cell research had the greatest positive impact.

These include the ability to bring new, innovative products to the market; progress in oncology, such as the approval of Genentech's drug Avastin for breast cancer and advances in the use of gene therapy, despite some setbacks; continuing progress in research on stem cells; the emergence of treatments for previously untreated diseases; and solutions for food and fuel shortages, such as biocrops and biofuels.

«The discovery of the novel progenitor represents a fundamental advance in this field and potentially to the liver regeneration field using cell therapy,» said the study's senior author, Valerie Gouon - Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount Sicell therapy,» said the study's senior author, Valerie Gouon - Evans, PharmD, PhD, Assistant Professor, in the Department of Developmental and Regenerative Biology, Black Family Stem Cell Institute, at the Icahn School of Medicine at Mount SiCell Institute, at the Icahn School of Medicine at Mount Sinai.

For his part, Collins, who has led NIH since 2009 and been kept on by the Trump administration, pointed to an array of promising NIH activities, including the development of new technologies to provide insights into human brain circuitry and function through the Brain Research through Advancing Innovative Neuroethologies (BRAIN initiative) and the use of the gene - editing tool CRISPR - Cas9 to correct mutations and clear the way to develop and test a «curative therapy» for the first molecular disease: sickle cell disease.

Treatment for advanced melanoma has seen success with targeted therapies — drugs that interfere with division and growth of cancer cells by targeting key molecules — especially when multiple drugs are used in combination.

With a history of public blunders, can Advanced Cell Technology make embryonic stem - cell therapies a realCell Technology make embryonic stem - cell therapies a realcell therapies a reality?

The technical advances emerging from gene therapy have fueled the larger fields of cell and immune therapy, where DNA, immune molecules, and viruses are all elements to be manipulated, in concert or one at a time.

While the disease can take many forms, recent advances have better characterized how lymphoma cells proliferate and interact with other cells and tissues, leading to the development of powerful, targeted therapies with fewer side effects than traditional approaches.

The journal's home page explains that translational medicine «builds on basic research advances — studies of biological processes using cell cultures, for example, or animal models — and uses them to develop new therapies or medical procedures.»

The new study shows that a «constitutively active» signaling circuit can trigger cells to grow into tumors and drive therapy resistance in advanced prostate cancer.

Advances in understanding the cells and molecules that transmit pain signals are providing new targets for drugs that could relieve various kinds of pain — including those poorly controlled by existing therapies

Hematopoietic stem cell transplantation (HSCT), once considered an effective yet risky alternative to drug therapy for blood cancer, has become more accessible and successful in a wide range of patients as a result of major advances in transplant strategies and technologies.

Results from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing autologous stem cell transplants (ASCT).

«Because of relatively low survival rates and their advancing age, these patients tend to be poor candidates for aggressive therapies, like a bone marrow transplant,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores Cancer Center.

This technological advance will provide investigators with a new tool for comprehensive mapping of cell - cell communication, which is important in all aspects of cancer development, maintenance, and response to therapy.

While neural stem cell therapies are already advancing to clinical trials, this research raises cautionary notes about moving to human therapy too quickly, said Tuszynski.

In recent clinical trials, CAR T cell therapy has dramatically improved the outcomes of blood cancer patients with advanced, otherwise untreatable forms of leukemia and lymphoma.

Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART).

«Stem cell transplants may advance ALS treatment by repair of blood - spinal cord barrier: ALS mice improved with stem cell therapy; first step for science in finding better treatment.»

NRG Oncology researchers recently developed and validated a nomogram that can predict 2 - year and 5 - year overall survival (OS) and progression - free survival (PFS) for patients with local - regionally advanced oropharyngeal squamous cell carcinoma (OPSCC) treated primarily with radiation - based therapy.

So for 17 patients with advanced melanoma who didn't have tumor - fighting T cells and had failed existing treatments, Rosenberg's team tried gene therapy.

That's the question raised by some perplexing new studies, providing another complication for researchers who are trying to develop advanced therapies based on neurons grown from stem cells.

Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies.

Researchers enrolled 102 patients in with advanced non-small cell lung cancer in the phase 1b study to evaluate the durvalumab and tremelimumab combination therapy.

The ability to make expand the number of iNKT cells is expected to advance cancer therapies.

But there's reason for optimism - recent advances in screening and treatment, such as CAR T cell therapy, mean patient outcomes and quality of life are continuing to improve.

The Okyanos Center for Regenerative Medicine was founded in 2011 to offer patients the most advanced and safe medical treatments in regenerative medicine, and to partner with leading universities and research labs in collecting data that advances the field of stem cell therapy.

ARandomized, Phase III, Double - Blind Placebo - Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum - Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-Small Cell Lung Cancer

The NSU Cell Therapy Institute is housed in the university's newly opened $ 100 million, Center for Collaborative Research (CCR), which is one of the largest (215,000 square feet) and most advanced research facilities in Florida.

Besides being a potentially important advance for the patients with the greatest needs, PEC - Direct is also considered a stepping stone to cell therapy for all insulin requiring patients.

Housed in NSU's Center for Collaborative Research, the NSU Cell Therapy Institute focuses on advancing new approaches to cancer immunotherapy and regenerative medicine